RecruitingNCT06613334
Using speech to monitor medication use in schizophrenia
About this title
Read the official source — NCT06613334Interventional studyAges 18–60France
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
What will I do during this study?
Participants complete voice interviews and questionnaires through the CALLYOPE app. They also have four blood tests: at enrolment, at months 2 and 4, and at the six-month study visit. The tests measure blood levels of the antipsychotic medication.
- Listed locations
- Paris and 1 more locationSee all locations and recruitment
- Participation duration
- 6 months
- Number of visits
- 4 blood tests through the 6-month visit
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 4, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- Centre Hospitalier St Anne
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological, Other
- Locations
- France
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06613334
- Official title
Show the full official title
Automatic Measurement of Antipsychotic Medication Adherence in Schizophrenia Through Speech (OBSERVSPEECH)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Paris
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre Hospitalier St Anne.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
